Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design

David R. Coghill (Lead / Corresponding author), Tobias Banaschewski, Michel Lecendreux, Mats Johnson, Alessandro Zuddas, Colleen S. Anderson, Richard Civil, Matthew Dauphin, Nicholas Higgins, Andrew Lyne, Maria Gasior, Liza A. Squires

    Research output: Contribution to journalArticlepeer-review

    31 Citations (Scopus)
    217 Downloads (Pure)

    Abstract

    In this phase 3 extension study, the long-term maintenance of efficacy of lisdexamfetamine dimesylate (LDX) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) was evaluated using a randomized-withdrawal study design.
    Original languageEnglish
    Pages (from-to)647
    Number of pages657
    JournalJournal of the American Academy of Child & Adolescent Psychiatry
    Volume53
    Issue number6
    Early online date3 Mar 2014
    DOIs
    Publication statusPublished - 2014

    Fingerprint Dive into the research topics of 'Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design'. Together they form a unique fingerprint.

    Cite this